Compare Sibanye Stillwater Ltd (SBSW) vs Vir Biotechnology Inc. Common Stock (VIR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Sibanye Stillwater Ltd vs Vir Biotechnology Inc. Common Stock — how do they compare? Sibanye Stillwater Ltd trades at $9.44 (market cap $6.99B), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B). The key difference: Sibanye Stillwater Ltd is far larger — about 3.9× Vir Biotechnology Inc. Common Stock's market cap, and Sibanye Stillwater Ltd pays a 8.17% dividend while Vir Biotechnology Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Sibanye Stillwater Ltd for 51 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.
| SBSW | VIR | |
|---|---|---|
Market Cap | $6.99B | $1.80B |
Volume | 3,905,859 | 1,782,836 |
Sector | Basic Materials | Health |
52-Week High | $21.12 | $11.78 |
52-Week Low | $8.00 | $5.12 |
Typical Hold Time | 51 Days | 0 Days |
Enterprise Value | $7.89B | $1.36B |
Dividend Yield | 8.17% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
SBSW trades at $9.42, down 4.75% on the day, amid a bearish technical signal. The company reported a net loss of $5.17 billion in 2025 despite revenue of $129.68 billion, though profitability is projected to improve significantly in 2026. Analyst consensus is a Moderate Buy with a $14.25 price target. Recent news highlights strong first-half 2026 results, including 54% revenue growth and a surge in operating cash flow, signaling a potential turnaround.
The outlook for SBSW hinges on executing its growth roadmap and capital discipline. Investment opportunities include attractive valuation multiples and projected earnings recovery, but risks persist from commodity price volatility, high debt levels, and operational challenges in South African mining. The stock offers value if management delivers on its 2027-2028 targets.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Sibanye Stillwater Ltd
Sibanye Stillwater Ltd is a South Africa-focused mining company. The Group currently owns and operates five underground and surface gold operations in South Africa: the Cooke, DRDGOLD, Driefontein, and Kloof operations in the West Witwatersrand region, and the Beatrix Operation in the southern Free State province. In addition to mining, the company owns and manages extraction and processing facilities at its operations, where gold-bearing ore is treated and beneficiated to produce gold dore. The gold dore is further refined at Rand Refinery into gold bars with a purity of at least 99.5% and is then sold on international markets. Sibanye holds a 44% interest in Rand Refinery, global refiners of gold, and the largest in Africa. Rand Refinery markets gold to customers around the world.
Read more on SBSW →About Vir Biotechnology Inc. Common Stock
Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.
Read more on VIR →
